A New Ray of Hope for Children with Food Allergies Children with severe food allergies often live in constant fear of accidental exposure to allergy-triggering foods. Even the smallest trace of an allergenic food can trigger severe reactions such as difficulty in breathing. However, a recent study led by scientists at the Stanford School of…

In a significant advancement for individuals living with food allergies, a new study published in the New England Journal of Medicine reveals that the drug omalizumab, commonly known as Xolair, enables patients to tolerate higher doses of allergenic foods before developing a reaction. This breakthrough not only provides a potential safeguard against accidental exposure to…

A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume without an allergic reaction in a late-stage clinical trial. Nearly 67% of participants who completed the antibody treatment could consume a single dose of 600…

Credit: Unsplash/CC0 Public Domain A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of Medicine. The research will be published Feb. 25 in the New England Journal of Medicine. The…